6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
41m ago	Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Announces the Company’s Comprehensive Transformation Across Five Areas: Strategy; Product, Technology and Business; Finance; Capital; and FF’s AI Operating System
1h ago	Life360 Board of Directors Authorizes Up to $225 Million Multi-Year Share Repurchase Program to Offset Stock-Based Compensation Dilution
2h ago	Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
3h ago	New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
4h ago	United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026

About

14.37USD-0.17 -1.17%

Closed • Updated at 23:14 GMT+00:00

Market Cap$897.51M

Volume623.6K

Beta0.17

RSI55.28

Health TechnologyBiotechnology

Design Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026

Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates

Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates

Design Therapeutics to Participate in Upcoming Investor Conferences

Design Therapeutics Announces Plans to Initiate Patient Dosing of DT-818 in Myotonic Dystrophy Type-1 (DM1) in the First Half of 2026 and Reports Third Quarter 2025 Financial Results

Recent Videos

Via News: AI-Designed Antibody BD200 Outperfo | Oil Hits $100 as US Threatens Hormu

Via News: AI-Designed Antibody BD200 Outperfo | Oil Hits $100 as US Threatens Hormu

Apr 19, 2026

AI Designs Gut Cures!

AI Designs Gut Cures!

Mar 04, 2026

Eyecelerator @ Park City 2025 | Anterior Segment Showcase: Design Therapeutics, Inc

Eyecelerator @ Park City 2025 | Anterior Segment Showcase: Design Therapeutics, Inc

Jan 09, 2026

PRICE BREAKOUT : DSGN STOCK ANALYSIS | DESIGN THERAPEUTICS STOCK

PRICE BREAKOUT : DSGN STOCK ANALYSIS | DESIGN THERAPEUTICS STOCK

Dec 15, 2025

Community Chat

Ask AI